The shingles vaccine protects for at least 7 years, but protection likely lasts much longer

The shingles vaccine (Shingrix) has been shown to protect against shingles for at least 7 years in clinical trials. However, researchers believe the protection probably lasts much longer—possibly for life—because the vaccine creates a strong immune response that doesn't fade the way immunity from natural infection does. The longest follow-up data available comes from studies that tracked vaccinated people for 7 years, and protection remained high throughout that period.

This is different from older shingles vaccines like Zostavax, which lost effectiveness over time and required a booster shot after 5 years. Shingrix appears to work differently: it teaches your immune system to remember how to fight the virus for years without needing a reminder dose.

The real-world answer is that we don't yet know if you'll ever need a booster, because the vaccine hasn't been in use long enough. Shingrix was approved by the FDA in 2017, so the longest anyone has been protected is about 7 years. Researchers are continuing to follow vaccinated people to see whether protection holds beyond that.

Key Takeaways

  • Shingrix protects against shingles for at least 7 years based on clinical trial data, and researchers believe protection likely lasts much longer.
  • Unlike the older Zostavax vaccine, Shingrix does not require a booster shot after 5 years.
  • The CDC currently recommends a single 2-dose series of Shingrix for adults 50 and older, with no booster recommended at this time.
  • If you received Zostavax in the past, you can still get Shingrix at least 12 months later for stronger, longer-lasting protection.
  • Ongoing studies continue to track how long Shingrix protection lasts, and booster recommendations may change if data shows protection fades.

Why Shingrix protection lasts so much longer than older vaccines

Shingrix uses a different technology than Zostavax, the shingles vaccine used before 2017. Zostavax was a live vaccine—it contained a weakened form of the virus itself. Live vaccines trigger an immune response, but that response tends to weaken over time, which is why Zostavax protection dropped significantly after 5 years.

Shingrix is a recombinant vaccine, meaning it doesn't contain any virus at all. Instead, it contains a piece of a viral protein plus a booster ingredient that tells your immune system to pay close attention. This combination creates a much stronger and more durable immune memory. Your body learns to recognize and fight the virus without the vaccine wearing out.

The booster ingredient in Shingrix—called an adjuvant—is particularly important. It's designed to keep your immune response strong for years. This is why Shingrix protection has held steady through 7 years of follow-up, while Zostavax protection was already fading by year 5.

What the CDC recommends right now

The CDC recommends that all adults 50 and older receive Shingrix, given as two doses spaced 2 to 6 months apart. There is currently no booster dose recommended after you complete the two-dose series.

If you received Zostavax in the past, you don't need to wait for Shingrix protection to fade before switching. The CDC recommends getting Shingrix at least 12 months after your Zostavax dose. You can get it sooner if needed, but waiting 12 months is preferred because it gives your immune system time to settle between vaccines.

Adults 19 and older with weakened immune systems (from HIV, organ transplant, or certain medications) should also get Shingrix, regardless of whether they had Zostavax before. For this group, the spacing between doses can be shorter—as little as 1 to 2 months—because their doctors may want faster protection.

How researchers measure vaccine protection over time

When vaccine makers test how long protection lasts, they follow vaccinated people for years and measure two things: whether they get sick, and how strong their immune response remains. For Shingrix, researchers have tracked people for 7 years and measured both the rate of shingles cases and the level of antibodies in the blood.

The results show that both the antibody levels and the protection against shingles stayed strong through year 7. This is the data the CDC uses to decide whether a booster is needed. If protection had dropped significantly by year 5 or 6, the CDC would likely recommend a booster, the way they do for some other vaccines.

The challenge is that 7 years of data is still relatively short in vaccine terms. Some vaccines protect for decades or life, but you can only know that by following people for decades. Researchers are continuing to track Shingrix recipients to see what happens in years 8, 9, 10, and beyond.

What might change in the future

If long-term studies show that Shingrix protection begins to fade after 10 or 15 years, the CDC could recommend a booster dose at that point. However, this is not certain. Some vaccines maintain protection for life even though they're not boosted, and Shingrix may be one of them.

Another possibility is that boosters might be recommended only for certain groups—for example, people with weakened immune systems or those at very high risk of severe shingles. The CDC will make these decisions based on data from ongoing studies.

In the meantime, if you've completed the two-dose Shingrix series, you have strong protection against shingles. You don't need to do anything else unless your doctor tells you otherwise or the CDC changes its recommendations.

Protection if you've already had shingles

If you've had shingles in the past, you should still get Shingrix. Having shingles once doesn't mean you're immune—you can get it again, though it's less common. Shingrix protects you from future episodes.

You can get Shingrix any time after your shingles rash has healed, though waiting 12 months is preferred if possible. If you need protection sooner, you can get it earlier. The vaccine works the same way whether or not you've had shingles before.

Frequently Asked Questions

Do I need a booster shot after getting Shingrix?

Not currently. The CDC does not recommend a booster dose after you complete the two-dose Shingrix series. Protection has remained strong for at least 7 years in studies. If future research shows protection fades, the CDC may change this recommendation, but that hasn't happened yet.

What if I got Zostavax years ago—do I still need Shingrix?

Yes. Zostavax protection fades over time, and Shingrix offers much stronger, longer-lasting protection. You can get Shingrix at least 12 months after Zostavax, though you can get it sooner if needed. The two doses of Shingrix will give you better protection than Zostavax alone.

How do doctors know Shingrix lasts 7 years if it's only been used since 2017?

Researchers followed vaccinated people in clinical trials for 7 years and measured both shingles cases and antibody levels. Both stayed strong throughout. However, we won't know if protection lasts longer than 7 years until more time passes and more data is collected.

If I'm vaccinated and still get shingles, does that mean the vaccine failed?

Shingrix is about 90% effective at preventing shingles in people 50 and older, which means roughly 1 in 10 vaccinated people may still develop it. If you do get shingles after vaccination, it's usually less severe than it would have been without the vaccine. This is still considered vaccine success.

Will I need a booster when I'm older?

That's unknown right now. If you get Shingrix at 50, we don't yet know whether you'll need a booster at 70 or 80. Researchers are still collecting data. The CDC will update its recommendations if studies show protection fades or if certain age groups need boosters.